Federal Register / Vol. 88, No. 167 / Wednesday, August 30, 2023 / Notices 59927 

treatment under FTC Rule 4.9(c), and 

the General Counsel grants that request. 

The FTC Act and other laws that the 

Commission administers permit the 

collection of public comments to 

consider and use in this proceeding as 

appropriate. The Commission will 

consider all timely and responsive 

public comments that it receives on or 

before October 30, 2023. For 

information on the Commission’s 

privacy policy, including routine uses 

permitted by the Privacy Act, see 

https://www.ftc.gov/site-information/ 

privacy-policy. 

Josephine Liu, 

Assistant General Counsel for Legal Counsel. 

[FR Doc. 2023–18766 Filed 8–29–23; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

[Docket No. ATSDR–2023–0004] 

Availability of Five Draft Toxicological 

Profiles and One Draft Interaction 

Profile 

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Agency for Toxic 

Substances and Disease Registry 

(ATSDR), within the Department of 

Health and Human Services (HHS), 

announces the opening of a docket to 

obtain comments on drafts of five 

updated toxicological profiles, and one 

draft interaction profile: Creosote, 

Nickel, 1,2-Dichloroethene, Vinyl 

acetate, Acrylonitrile, and the 

Interaction Profile for Selected Metallic 

Ions. This action is necessary as this is 

the opportunity for members of the 

public and organizations to submit 

comments on drafts of the profiles. The 

intended effect of this action is to 

ensure that the public can note any 

pertinent additional information or 

reports on studies about the health 

effects of these six profiles for review. 

DATES: Written comments must be 

received on or before November 28, 

2023. 

ADDRESSES: You may submit comments, 

identified by Docket No. ATSDR–2023– 

0004 by either of the methods listed 

below. Do not submit comments by 

email. ATSDR does not accept 

comments by email. 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Agency for Toxic Substances 

and Disease Registry, Office of 

Innovation and Analytics, 4770 Buford 

Highway, Mail Stop S106–5, Atlanta, 

GA 30341–3717. Attn: Docket No. 

ATSDR–2023–0004. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. All relevant comments 

received will be posted without change 

to http://www.regulations.gov, including 

any personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

http://www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Farhana Rahman, Agency for Toxic 

Substances and Disease Registry, Office 

of Innovation and Analytics, 1600 

Clifton Rd. NE, Mail Stop S106–5, 

Atlanta, GA 30329–4027; Email: 

ATSDRToxProfileFRNs@cdc.gov; Phone: 

1–800–232–4636. 

SUPPLEMENTARY INFORMATION: ATSDR 

has prepared drafts of five updated 

toxicological profiles and one 

interaction profile based on current 

understanding of the health effects and 

availability of new studies and other 

information since their initial release. 

All toxicological profiles issued as 

‘‘Drafts for Public Comment’’ represent 

the result of ATSDR’s evidence-based 

evaluations to provide important 

toxicological information on priority 

hazardous substances to the public and 

health professionals. ATSDR considers 

key studies for these substances during 

the profile development process, using 

a systematic review approach. To that 

end, ATSDR is seeking public 

comments and additional information or 

reports on studies about the health 

effects of these substances for review 

and potential inclusion in the profiles. 

ATSDR will evaluate the quality and 

relevance of such data or studies for 

possible inclusion in the profile. 

Legislative Background 

The Superfund Amendments and 

Reauthorization Act of 1986 (SARA) [42 

U.S.C. 9601 et seq.] amended the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act of 1980 (CERCLA or Superfund) [42 

U.S.C. 9601 et seq.] by establishing 

certain requirements for ATSDR and the 

U.S. Environmental Protection Agency 

(EPA) regarding the hazardous 

substances most commonly found at 

facilities on the CERCLA National 

Priorities List. Among these statutory 

requirements is a mandate for the 

Administrator of ATSDR to prepare 

toxicological profiles for each substance 

included on the priority list of 

hazardous substances [also called the 

Substance Priority List (SPL)]. This list 

identifies 275 hazardous substances that 

ATSDR has determined pose the most 

significant potential threat to human 

health. The SPL is available online at 

http://www.atsdr.cdc.gov/SPL. ATSDR 

is also mandated to revise and publish 

updated toxicological profiles, as 

necessary, to reflect updated health 

effects and other information. 

In addition, CERCLA provides ATSDR 

with the authority to prepare 

toxicological profiles for substances not 

found on the SPL. CERCLA authorizes 

ATSDR to establish and maintain an 

inventory of literature, research, and 

studies on the health effects of toxic 

substances (CERCLA Section 

104(i)(1)(B); 42 U.S.C. 9604(i)(1)(B)); to 

respond to requests for health 

consultations (CERCLA Section 

104(i)(4); 42 U.S.C. 9604(i)(4)); and to 

support the site-specific response 

actions conducted by the agency 

(CERCLA Section 104(i)(6); 42 U.S.C. 

9604(i)(6)). 

ATSDR has now prepared drafts of 

five updated toxicological profiles, and 

one interaction profile based on current 

understanding of the health effects and 

availability of new studies and other 

information since their initial release. 

Availability 

The draft toxicological profiles and 

interaction profile are available online 

at http://www.regulations.gov, Docket 

No. ATSDR–2023–0004 and at http://

www.atsdr.cdc.gov/ToxProfiles. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 

posted on https://www.regulations.gov. 

Therefore, do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

ATSDR will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near duplicate examples of a mass-mail 


lotter on DSK11XQN23PROD with NOTICES1
59928 Federal Register / Vol. 88, No. 167 / Wednesday, August 30, 2023 / Notices 

campaign. Do not submit comments by 

email. ATSDR does not accept 

comments by email. 

Donata Green, 

Acting Associate Director, Office of Policy, 

Planning and Partnerships, Agency for Toxic 

Substances and Disease Registry. 

[FR Doc. 2023–18730 Filed 8–29–23; 8:45 am] 

BILLING CODE 4163–70–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2023–N–1053] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Customer/Partner 

Service Satisfaction Surveys 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA or Agency) is 

announcing that a proposed collection 

of information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Submit written comments 

(including recommendations) on the 

collection of information by September 

29, 2023. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be submitted to https://

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

Review—Open for Public Comments’’ or 

by using the search function. The OMB 

control number for this information 

collection is 0910–0360. Also include 

the FDA docket number found in 

brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

JonnaLynn Capezzuto, Office of 

Operations, Food and Drug 

Administration, Three White Flint 

North, 10A–12M, 11601 Landsdown St., 

North Bethesda, MD 20852, 301–796– 

3794, PRAStaff@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Customer/Partner Service Satisfaction 

Surveys 

OMB Control Number 0910–0360— 

Extension 

Under section 1003 of the Federal 

Food, Drug, and Cosmetic Act (21 U.S.C. 

393), FDA is authorized to conduct 

research and public information 

programs about regulated products and 

responsibilities of the Agency. 

Executive Order 12862, entitled ‘‘Setting 

Customer Service Standard,’’ directs 

Federal Agencies that ‘‘provide 

significant services directly to the 

public’’ to ‘‘survey customers to 

determine the kind and quality of 

services they want and their level of 

satisfaction with existing services.’’ FDA 

is seeking to extend OMB approval to 

conduct customer service satisfaction 

surveys to implement Executive Order 

12862. Participation in the surveys is 

voluntary. This request covers 

customer/partner (including State and 

local governments) service satisfaction 

surveys of regulated entities, such as 

food processors; cosmetic, drug, 

biologic, and medical device 

manufacturers; animal drugs, animal 

food and feed; tobacco products; and 

consumers and health professionals. 

FDA will use the information from 

these surveys to identify strengths and 

weaknesses in service to customers/ 

partners and to make improvements. 

The surveys will measure timeliness, 

appropriateness, clarity, and accuracy of 

information, courtesy, and problem 

resolution in the context of individual 

programs. 

FDA estimates conducting 

approximately 20 customer/partner 

service satisfaction surveys per year, 

each requiring an average of 25 minutes 

for review and completion. We estimate 

respondents to these surveys to be 

between 100 and 20,000 customers/ 

partners. Some of these surveys will be 

repeats of earlier surveys for purposes of 

monitoring customer/partner service 

and developing long-term data. 

Respondents to this collection of 

information cover a broad range of 

stakeholders who have experience with 

certain products regulated by or services 

provided by FDA. 

In the Federal Register of April 25, 

2023 (88 FR 24992), FDA published a 

60-day notice requesting public 

comment on the proposed collection of 

information. One comment was received 

in support of this information 

collection. 

FDA estimates the burden of this 

collection of information as follows: 

TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1

Activity Number of 

respondents 

Number of 

responses per 

respondent 

Total annual 

responses 

Average burden per 

response Total hours 

Mail, telephone, web-based survey ................ 85,000 1 85,000 0.42 (25 minutes) ............... 35,700 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

Since the last OMB approval of this 

information collection request, FDA 

submitted three requests to increase the 

total burden hours. Therefore, this 

request for extension of OMB approval 

adjusts the number of respondents by an 

increase of 30,000 and the total burden 

hours by an increase of 21,950. 

Dated: August 24, 2023. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2023–18635 Filed 8–29–23; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Meeting of the National Advisory 

Council on Migrant Health 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, this 

notice announces that the National 

Advisory Council on Migrant Health 

(NACMH) has scheduled a public 

meeting. Information about NACMH 

and the agenda for this meeting can be 

found on NACMH’s website at https:// 

www.hrsa.gov/advisory-committees/ 

migrant-health. 

DATES: November 1–2, 2023, 9:00 a.m.– 

5:00 p.m. Eastern Standard Time. 

ADDRESSES: This meeting will be held 

in-person at 5600 Fishers Lane, 


lotter on DSK11XQN23PROD with NOTICES1